|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Vertex Pharmaceuticals, Inc.
| | | Phone: | (617) 444-6100 | Year Established: | 1989 | Ticker: | VRTX | Exchange: | NASDAQ | Main Contact: | Jeffrey Leiden, M.D., Ph.D., President & CEO | | Other Contacts: | Reshma Kewalramani, M.D., CMO Reshma Kewalramani, M.D., Senior VP, Clinical Development and Medical Affairs David Altshuler, M.D., Ph.D., Executive VP, Global Research & CSO Ian F. Smith, Executive VP, COO Stuart A. Arbuckle, Executive VP, & CCO Tom Graney, Senior VP & CFO Amit K. Sachdev, Executive VP & Chief Regulatory Officer Michael J. Parini, CLO
| | Company Description | Vertex Pharmaceuticals is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and cystic fibrosis. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline. | |
|
|
|
|
|